Advertisement

Decision Models and Technology in Psychiatry

  • Daniel S. Barron
    Correspondence
    Address correspondence to Daniel Barron, M.D., Ph.D.
    Affiliations
    Department of Psychiatry, Yale University, New Haven, Connecticut
    Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington
    Departments of Psychiatry and Anesthesiology and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
    Search for articles by this author
      SEE CORRESPONDING ARTICLE ON PAGE 236
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kelley M.E.
        • Choi K.S.
        • Rajendra J.K.
        • Craighead W.E.
        • Rakofsky J.J.
        • Dunlop B.W.
        • Mayberg H.S.
        Establishing evidence for clinical utility of a neuroimaging biomarker in major depressive disorder: Prospective testing and implementation challenges.
        Biol Psychiatry. 2021; 90: 236-242
        • First M.B.
        • Williams J.B.W.
        • Spitzer R.L.
        • Gibbon M.
        Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT).
        Biometrics Research, New York State Psychiatric Institute, New York2007
        • Hamilton M.
        A rating scale for depression.
        J Neurol Neurosurg Psychiatry. 1960; 23: 56-62
        • Dunlop B.W.
        • Kelley M.E.
        • McGrath C.L.
        • Craighead W.E.
        • Mayberg H.S.
        Preliminary findings supporting insula metabolic activity as a predictor of outcome to psychotherapy and medication treatments for depression.
        J Neuropsychiatry Clin Neurosci. 2015; 27: 237-239
        • McGrath C.L.
        • Kelley M.E.
        • Holtzheimer P.E.
        • Dunlop B.W.
        • Craighead W.E.
        • Franco A.R.
        • et al.
        Toward a neuroimaging treatment selection biomarker for major depressive disorder.
        JAMA Psychiatry. 2013; 70: 821-829
        • Hollander J.E.
        • Chase M.
        Evaluation of the adult with chest pain in the emergency department.
        (Available at:) (Accessed June 6, 2021)
        • Levy D.
        • Brink S.
        A Change of Heart: Unraveling the Mysteries of Cardiovascular Disease.
        Vintage Books, New York2005
        • Abramson M.
        Restricted combinations and compositions.
        Fibonacci Q. 1976; 14: 439-452
        • Barron D.S.
        Commentary: The ethical challenges of machine learning in psychiatry: A focus on data, diagnosis, and treatment [published online ahead of print May 12].
        Psychol Med. 2021;
        • Barron D.
        Reading Our Minds: The Rise of Big Data Psychiatry.
        Columbia Global Reports, Columbia University Press, New York2021

      Linked Article